Atlas FDA

HELIOS II ABLATION CATHETER

FDA premarket approval P050029 · decided 2008-10-10

Approval details

PMA number
P050029
Trade name
HELIOS II ABLATION CATHETER
Generic name
Cardiac ablation percutaneous catheter
Applicant
Stereotaxis, Inc.
Date received
2005-08-23
Decision date
2008-10-10
Days to decision
1144 days
Decision code
APPR
Product code
LPB
Advisory committee
Cardiovascular
Expedited review
No
Location
St. Louis, MO
Statement
APPROVAL FOR THE HELIOS II ABLATION CATHETER. THE HELIOS II ABLATION CATHETER IS INTENDED FOR CARDIAC ELECTROPHYSIOLOGICAL MAPPING, DELIVERING DIAGNOSTIC PACING STIMULI, AND FOR THE CREATION OF ENDOCARDIAL LESIONS TO TREAT PATIENTS WITH SUPRAVENTRICULAR (SVT) TACHYCARDIAS.IT IS INTENDED TO ELIMINATE ATRIOVENTRICULAR REENTRANT TACHYCARDIA (AVRT) IN PATIENTS WITH OVERT OR CONCEALED ACCESSORY PATHWAYS, TO ELIMINATE AV NODAL RE-ENTRANT TACHYCARDIA (AVNRT), AND TO CREATE COMPLETE AV NODAL BLOCK IN PA

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Synchrony (K253473)Stereotaxis, Inc.2026-04-01
Stereotaxis GenesisX RMN with Navigant ™ Workstation (NWS) (K251792)Stereotaxis, Inc.2025-11-06
MAGiC Sweep™ EP Mapping Catheter (K250590)Stereotaxis, Inc.2025-07-23
Stereotaxis Genesis RMN with Navigant Workstation (NWS) and Cardiodrive System (K193147)Stereotaxis, Inc.2020-03-05
Niobe® Magnetic Navigation System (MNS) with Navigant Workstation (NWS) and Cardiodri (K192775)Stereotaxis, Inc.2019-10-30
Steerable catheter control system (K183027)Stereotaxis, Inc.2019-09-06
Vdrive system, Vdrive Duo, Vdrive with V-Sono (K150312)Stereotaxis, Inc.2015-06-17
VDRIVE SYSTEM/ VDRIVE DUO/ VDRIVE WITH V-CAS (K141530)Stereotaxis, Inc.2014-12-18